Mogamulizumab: an exciting antibody for autoimmunity
Martine Bagot, MD, PhD, of Saint Louis Hospital, Paris, France, discusses the exciting new approval of the antibody mogumulizumab for cutaneous T-cell lymphoma. Speaking at the European Organisation f...
Author: VJHemOnc
Added: 10/02/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Cutaneous T cell lymphoma | France Health | Hospitals | Lymphoma | T-cell Lymphoma